Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03515083 · ClinicalTrials.gov registry record · NA
Better Outcomes for Anticoagulation Treatment Through Observation of Atrial Rhythm
A NA study, sponsored by Saint Luke's Health System.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT03515083 is a NA study that has completed, run by Saint Luke's Health System. The registered enrollment target is 100 participants.
The verdict
NCT03515083, a NA study, has completed, sponsored by Saint Luke's Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
There is a need to determine actual compliance of direct oral anticoagulants and how to improve this to reduce risk of stroke in patients with atrial fibrillation. Mobile health tools have been implemented world-wide in various patient populations as means of reducing cardiovascular risk and improving disease management. Results of these interventions have been mixed with some interventions demonstrating significant improvement while others demonstrated no difference between the intervention group and the control group. More importantly, these studies indicate that implementation of mobile health tools is feasible in various patient populations and it may just be a matter of finding the correct intervention for a given disease state. The aim of this study is to increase awareness of atrial fibrillation as a means of improving compliance with anticoagulant medication.
Interventions
- DEVICE Alive Cor Kardia mobile electrocardiogram monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2017-07-17 |
| Est. Completion | 2022-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03515083
The ClinicalTrials.gov registry entry for NCT03515083 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Saint Luke's Health System, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Alive Cor Kardia mobile electrocardiogram monitor is the first listed.
NCT03515083 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03515083 about?
NCT03515083 is a clinical study titled "Better Outcomes for Anticoagulation Treatment Through Observation of Atrial Rhythm". There is a need to determine actual compliance of direct oral anticoagulants and how to improve this to reduce risk of stroke in patients with atrial fibrillation. Mobile health tools have been implemented world-wide in various patient populations as means of reducing cardiovascular risk and improvi...
What is the current status of trial NCT03515083?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2017-07-17. Estimated completion is 2022-06-01.
What interventions are being tested in trial NCT03515083?
The interventions under investigation include: Alive Cor Kardia mobile electrocardiogram monitor (DEVICE).
Who is sponsoring clinical trial NCT03515083?
This trial is sponsored by Saint Luke's Health System, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.